Global Childhood Vaccines Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Childhood vaccination against diseases such as measles, meningitis and pneumonia, helps protect the developing immune systems of infants and prevents 2-3 million childhood deaths every year
LPI (LP Information)' newest research report, the “Childhood Vaccines Industry Forecast” looks at past sales and reviews total world Childhood Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Childhood Vaccines sales for 2023 through 2029. With Childhood Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Childhood Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Childhood Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Childhood Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Childhood Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Childhood Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Childhood Vaccines.
The global Childhood Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Childhood Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Childhood Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Childhood Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Childhood Vaccines players cover GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Childhood Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Childhood Vaccines market?
What factors are driving Childhood Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Childhood Vaccines market opportunities vary by end market size?
How does Childhood Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Childhood vaccination against diseases such as measles, meningitis and pneumonia, helps protect the developing immune systems of infants and prevents 2-3 million childhood deaths every year
LPI (LP Information)' newest research report, the “Childhood Vaccines Industry Forecast” looks at past sales and reviews total world Childhood Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Childhood Vaccines sales for 2023 through 2029. With Childhood Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Childhood Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Childhood Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Childhood Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Childhood Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Childhood Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Childhood Vaccines.
The global Childhood Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Childhood Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Childhood Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Childhood Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Childhood Vaccines players cover GSK, Sanofi, Merck, Pfizer, Jintan, CSL, MedImmune LLC, J&J(Crucell) and China National Biotec, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Childhood Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Recombinant Vaccines
- Viral Vaccines
- Polysaccharide Vaccines
- Others
- Hospital
- Clinic
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Sanofi
- Merck
- Pfizer
- Jintan
- CSL
- MedImmune LLC
- J&J(Crucell)
- China National Biotec
- Tiantan
- Hualan
- Kangtai
- Hissen
What is the 10-year outlook for the global Childhood Vaccines market?
What factors are driving Childhood Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Childhood Vaccines market opportunities vary by end market size?
How does Childhood Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Childhood Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Childhood Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Childhood Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Childhood Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Childhood Vaccines Sales by Type
2.3.1 Global Childhood Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Childhood Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Childhood Vaccines Sale Price by Type (2018-2023)
2.4 Childhood Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Childhood Vaccines Sales by Application
2.5.1 Global Childhood Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Childhood Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Childhood Vaccines Sale Price by Application (2018-2023)
3 GLOBAL CHILDHOOD VACCINES BY COMPANY
3.1 Global Childhood Vaccines Breakdown Data by Company
3.1.1 Global Childhood Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Childhood Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Childhood Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Childhood Vaccines Revenue by Company (2018-2023)
3.2.2 Global Childhood Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Childhood Vaccines Sale Price by Company
3.4 Key Manufacturers Childhood Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Childhood Vaccines Product Location Distribution
3.4.2 Players Childhood Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHILDHOOD VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Childhood Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Childhood Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Childhood Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Childhood Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Childhood Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Childhood Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Childhood Vaccines Sales Growth
4.4 APAC Childhood Vaccines Sales Growth
4.5 Europe Childhood Vaccines Sales Growth
4.6 Middle East & Africa Childhood Vaccines Sales Growth
5 AMERICAS
5.1 Americas Childhood Vaccines Sales by Country
5.1.1 Americas Childhood Vaccines Sales by Country (2018-2023)
5.1.2 Americas Childhood Vaccines Revenue by Country (2018-2023)
5.2 Americas Childhood Vaccines Sales by Type
5.3 Americas Childhood Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Childhood Vaccines Sales by Region
6.1.1 APAC Childhood Vaccines Sales by Region (2018-2023)
6.1.2 APAC Childhood Vaccines Revenue by Region (2018-2023)
6.2 APAC Childhood Vaccines Sales by Type
6.3 APAC Childhood Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Childhood Vaccines by Country
7.1.1 Europe Childhood Vaccines Sales by Country (2018-2023)
7.1.2 Europe Childhood Vaccines Revenue by Country (2018-2023)
7.2 Europe Childhood Vaccines Sales by Type
7.3 Europe Childhood Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Childhood Vaccines by Country
8.1.1 Middle East & Africa Childhood Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Childhood Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Childhood Vaccines Sales by Type
8.3 Middle East & Africa Childhood Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Childhood Vaccines
10.3 Manufacturing Process Analysis of Childhood Vaccines
10.4 Industry Chain Structure of Childhood Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Childhood Vaccines Distributors
11.3 Childhood Vaccines Customer
12 WORLD FORECAST REVIEW FOR CHILDHOOD VACCINES BY GEOGRAPHIC REGION
12.1 Global Childhood Vaccines Market Size Forecast by Region
12.1.1 Global Childhood Vaccines Forecast by Region (2024-2029)
12.1.2 Global Childhood Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Childhood Vaccines Forecast by Type
12.7 Global Childhood Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Childhood Vaccines Product Portfolios and Specifications
13.1.3 GSK Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Childhood Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Childhood Vaccines Product Portfolios and Specifications
13.3.3 Merck Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Childhood Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Jintan
13.5.1 Jintan Company Information
13.5.2 Jintan Childhood Vaccines Product Portfolios and Specifications
13.5.3 Jintan Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jintan Main Business Overview
13.5.5 Jintan Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Childhood Vaccines Product Portfolios and Specifications
13.6.3 CSL Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Childhood Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Childhood Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Childhood Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Childhood Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Childhood Vaccines Product Portfolios and Specifications
13.11.3 Hualan Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Childhood Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Childhood Vaccines Product Portfolios and Specifications
13.13.3 Hissen Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Childhood Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Childhood Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Childhood Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Childhood Vaccines Segment by Type
2.2.1 Recombinant Vaccines
2.2.2 Viral Vaccines
2.2.3 Polysaccharide Vaccines
2.2.4 Others
2.3 Childhood Vaccines Sales by Type
2.3.1 Global Childhood Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Childhood Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Childhood Vaccines Sale Price by Type (2018-2023)
2.4 Childhood Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.5 Childhood Vaccines Sales by Application
2.5.1 Global Childhood Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Childhood Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Childhood Vaccines Sale Price by Application (2018-2023)
3 GLOBAL CHILDHOOD VACCINES BY COMPANY
3.1 Global Childhood Vaccines Breakdown Data by Company
3.1.1 Global Childhood Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Childhood Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Childhood Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Childhood Vaccines Revenue by Company (2018-2023)
3.2.2 Global Childhood Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Childhood Vaccines Sale Price by Company
3.4 Key Manufacturers Childhood Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Childhood Vaccines Product Location Distribution
3.4.2 Players Childhood Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR CHILDHOOD VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Childhood Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Childhood Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Childhood Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Childhood Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Childhood Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Childhood Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Childhood Vaccines Sales Growth
4.4 APAC Childhood Vaccines Sales Growth
4.5 Europe Childhood Vaccines Sales Growth
4.6 Middle East & Africa Childhood Vaccines Sales Growth
5 AMERICAS
5.1 Americas Childhood Vaccines Sales by Country
5.1.1 Americas Childhood Vaccines Sales by Country (2018-2023)
5.1.2 Americas Childhood Vaccines Revenue by Country (2018-2023)
5.2 Americas Childhood Vaccines Sales by Type
5.3 Americas Childhood Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Childhood Vaccines Sales by Region
6.1.1 APAC Childhood Vaccines Sales by Region (2018-2023)
6.1.2 APAC Childhood Vaccines Revenue by Region (2018-2023)
6.2 APAC Childhood Vaccines Sales by Type
6.3 APAC Childhood Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Childhood Vaccines by Country
7.1.1 Europe Childhood Vaccines Sales by Country (2018-2023)
7.1.2 Europe Childhood Vaccines Revenue by Country (2018-2023)
7.2 Europe Childhood Vaccines Sales by Type
7.3 Europe Childhood Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Childhood Vaccines by Country
8.1.1 Middle East & Africa Childhood Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Childhood Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Childhood Vaccines Sales by Type
8.3 Middle East & Africa Childhood Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Childhood Vaccines
10.3 Manufacturing Process Analysis of Childhood Vaccines
10.4 Industry Chain Structure of Childhood Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Childhood Vaccines Distributors
11.3 Childhood Vaccines Customer
12 WORLD FORECAST REVIEW FOR CHILDHOOD VACCINES BY GEOGRAPHIC REGION
12.1 Global Childhood Vaccines Market Size Forecast by Region
12.1.1 Global Childhood Vaccines Forecast by Region (2024-2029)
12.1.2 Global Childhood Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Childhood Vaccines Forecast by Type
12.7 Global Childhood Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Childhood Vaccines Product Portfolios and Specifications
13.1.3 GSK Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Sanofi
13.2.1 Sanofi Company Information
13.2.2 Sanofi Childhood Vaccines Product Portfolios and Specifications
13.2.3 Sanofi Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Sanofi Main Business Overview
13.2.5 Sanofi Latest Developments
13.3 Merck
13.3.1 Merck Company Information
13.3.2 Merck Childhood Vaccines Product Portfolios and Specifications
13.3.3 Merck Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Merck Main Business Overview
13.3.5 Merck Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Childhood Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Jintan
13.5.1 Jintan Company Information
13.5.2 Jintan Childhood Vaccines Product Portfolios and Specifications
13.5.3 Jintan Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Jintan Main Business Overview
13.5.5 Jintan Latest Developments
13.6 CSL
13.6.1 CSL Company Information
13.6.2 CSL Childhood Vaccines Product Portfolios and Specifications
13.6.3 CSL Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 CSL Main Business Overview
13.6.5 CSL Latest Developments
13.7 MedImmune LLC
13.7.1 MedImmune LLC Company Information
13.7.2 MedImmune LLC Childhood Vaccines Product Portfolios and Specifications
13.7.3 MedImmune LLC Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 MedImmune LLC Main Business Overview
13.7.5 MedImmune LLC Latest Developments
13.8 J&J(Crucell)
13.8.1 J&J(Crucell) Company Information
13.8.2 J&J(Crucell) Childhood Vaccines Product Portfolios and Specifications
13.8.3 J&J(Crucell) Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 J&J(Crucell) Main Business Overview
13.8.5 J&J(Crucell) Latest Developments
13.9 China National Biotec
13.9.1 China National Biotec Company Information
13.9.2 China National Biotec Childhood Vaccines Product Portfolios and Specifications
13.9.3 China National Biotec Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 China National Biotec Main Business Overview
13.9.5 China National Biotec Latest Developments
13.10 Tiantan
13.10.1 Tiantan Company Information
13.10.2 Tiantan Childhood Vaccines Product Portfolios and Specifications
13.10.3 Tiantan Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Tiantan Main Business Overview
13.10.5 Tiantan Latest Developments
13.11 Hualan
13.11.1 Hualan Company Information
13.11.2 Hualan Childhood Vaccines Product Portfolios and Specifications
13.11.3 Hualan Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hualan Main Business Overview
13.11.5 Hualan Latest Developments
13.12 Kangtai
13.12.1 Kangtai Company Information
13.12.2 Kangtai Childhood Vaccines Product Portfolios and Specifications
13.12.3 Kangtai Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Kangtai Main Business Overview
13.12.5 Kangtai Latest Developments
13.13 Hissen
13.13.1 Hissen Company Information
13.13.2 Hissen Childhood Vaccines Product Portfolios and Specifications
13.13.3 Hissen Childhood Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hissen Main Business Overview
13.13.5 Hissen Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Childhood Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Childhood Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 8. Global Childhood Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Childhood Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Childhood Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Childhood Vaccines Sale Price by Type (2018-2023) & (USD/Dose)
Table 12. Global Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 13. Global Childhood Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Childhood Vaccines Revenue by Application (2018-2023)
Table 15. Global Childhood Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Childhood Vaccines Sale Price by Application (2018-2023) & (USD/Dose)
Table 17. Global Childhood Vaccines Sales by Company (2018-2023) & (K Doses)
Table 18. Global Childhood Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Childhood Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Childhood Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Childhood Vaccines Sale Price by Company (2018-2023) & (USD/Dose)
Table 22. Key Manufacturers Childhood Vaccines Producing Area Distribution and Sales Area
Table 23. Players Childhood Vaccines Products Offered
Table 24. Childhood Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Childhood Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Childhood Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Childhood Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Childhood Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Childhood Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Childhood Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Childhood Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Childhood Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Childhood Vaccines Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Childhood Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Childhood Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Childhood Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Childhood Vaccines Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Childhood Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Childhood Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Childhood Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Childhood Vaccines Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Childhood Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Childhood Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Childhood Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Childhood Vaccines Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Childhood Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Childhood Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Childhood Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Childhood Vaccines
Table 60. Key Market Challenges & Risks of Childhood Vaccines
Table 61. Key Industry Trends of Childhood Vaccines
Table 62. Childhood Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Childhood Vaccines Distributors List
Table 65. Childhood Vaccines Customer List
Table 66. Global Childhood Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Childhood Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Childhood Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Childhood Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Childhood Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Childhood Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Childhood Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Childhood Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Childhood Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Childhood Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Childhood Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Childhood Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Childhood Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Childhood Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GSK Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Childhood Vaccines Product Portfolios and Specifications
Table 82. GSK Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Childhood Vaccines Product Portfolios and Specifications
Table 87. Sanofi Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Childhood Vaccines Product Portfolios and Specifications
Table 92. Merck Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Childhood Vaccines Product Portfolios and Specifications
Table 97. Pfizer Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Jintan Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Jintan Childhood Vaccines Product Portfolios and Specifications
Table 102. Jintan Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 103. Jintan Main Business
Table 104. Jintan Latest Developments
Table 105. CSL Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Childhood Vaccines Product Portfolios and Specifications
Table 107. CSL Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Childhood Vaccines Product Portfolios and Specifications
Table 112. MedImmune LLC Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Childhood Vaccines Product Portfolios and Specifications
Table 117. J&J(Crucell) Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Childhood Vaccines Product Portfolios and Specifications
Table 122. China National Biotec Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Childhood Vaccines Product Portfolios and Specifications
Table 127. Tiantan Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Childhood Vaccines Product Portfolios and Specifications
Table 132. Hualan Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Childhood Vaccines Product Portfolios and Specifications
Table 137. Kangtai Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Childhood Vaccines Product Portfolios and Specifications
Table 142. Hissen Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
Table 1. Childhood Vaccines Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Childhood Vaccines Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Recombinant Vaccines
Table 4. Major Players of Viral Vaccines
Table 5. Major Players of Polysaccharide Vaccines
Table 6. Major Players of Others
Table 7. Global Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 8. Global Childhood Vaccines Sales Market Share by Type (2018-2023)
Table 9. Global Childhood Vaccines Revenue by Type (2018-2023) & ($ million)
Table 10. Global Childhood Vaccines Revenue Market Share by Type (2018-2023)
Table 11. Global Childhood Vaccines Sale Price by Type (2018-2023) & (USD/Dose)
Table 12. Global Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 13. Global Childhood Vaccines Sales Market Share by Application (2018-2023)
Table 14. Global Childhood Vaccines Revenue by Application (2018-2023)
Table 15. Global Childhood Vaccines Revenue Market Share by Application (2018-2023)
Table 16. Global Childhood Vaccines Sale Price by Application (2018-2023) & (USD/Dose)
Table 17. Global Childhood Vaccines Sales by Company (2018-2023) & (K Doses)
Table 18. Global Childhood Vaccines Sales Market Share by Company (2018-2023)
Table 19. Global Childhood Vaccines Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Childhood Vaccines Revenue Market Share by Company (2018-2023)
Table 21. Global Childhood Vaccines Sale Price by Company (2018-2023) & (USD/Dose)
Table 22. Key Manufacturers Childhood Vaccines Producing Area Distribution and Sales Area
Table 23. Players Childhood Vaccines Products Offered
Table 24. Childhood Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Childhood Vaccines Sales by Geographic Region (2018-2023) & (K Doses)
Table 28. Global Childhood Vaccines Sales Market Share Geographic Region (2018-2023)
Table 29. Global Childhood Vaccines Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Childhood Vaccines Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Childhood Vaccines Sales by Country/Region (2018-2023) & (K Doses)
Table 32. Global Childhood Vaccines Sales Market Share by Country/Region (2018-2023)
Table 33. Global Childhood Vaccines Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Childhood Vaccines Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Childhood Vaccines Sales by Country (2018-2023) & (K Doses)
Table 36. Americas Childhood Vaccines Sales Market Share by Country (2018-2023)
Table 37. Americas Childhood Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Childhood Vaccines Revenue Market Share by Country (2018-2023)
Table 39. Americas Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 40. Americas Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 41. APAC Childhood Vaccines Sales by Region (2018-2023) & (K Doses)
Table 42. APAC Childhood Vaccines Sales Market Share by Region (2018-2023)
Table 43. APAC Childhood Vaccines Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Childhood Vaccines Revenue Market Share by Region (2018-2023)
Table 45. APAC Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 46. APAC Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 47. Europe Childhood Vaccines Sales by Country (2018-2023) & (K Doses)
Table 48. Europe Childhood Vaccines Sales Market Share by Country (2018-2023)
Table 49. Europe Childhood Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Childhood Vaccines Revenue Market Share by Country (2018-2023)
Table 51. Europe Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 52. Europe Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 53. Middle East & Africa Childhood Vaccines Sales by Country (2018-2023) & (K Doses)
Table 54. Middle East & Africa Childhood Vaccines Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Childhood Vaccines Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Childhood Vaccines Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Childhood Vaccines Sales by Type (2018-2023) & (K Doses)
Table 58. Middle East & Africa Childhood Vaccines Sales by Application (2018-2023) & (K Doses)
Table 59. Key Market Drivers & Growth Opportunities of Childhood Vaccines
Table 60. Key Market Challenges & Risks of Childhood Vaccines
Table 61. Key Industry Trends of Childhood Vaccines
Table 62. Childhood Vaccines Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Childhood Vaccines Distributors List
Table 65. Childhood Vaccines Customer List
Table 66. Global Childhood Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 67. Global Childhood Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Childhood Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 69. Americas Childhood Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Childhood Vaccines Sales Forecast by Region (2024-2029) & (K Doses)
Table 71. APAC Childhood Vaccines Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Childhood Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 73. Europe Childhood Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Childhood Vaccines Sales Forecast by Country (2024-2029) & (K Doses)
Table 75. Middle East & Africa Childhood Vaccines Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Childhood Vaccines Sales Forecast by Type (2024-2029) & (K Doses)
Table 77. Global Childhood Vaccines Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Childhood Vaccines Sales Forecast by Application (2024-2029) & (K Doses)
Table 79. Global Childhood Vaccines Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. GSK Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 81. GSK Childhood Vaccines Product Portfolios and Specifications
Table 82. GSK Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 83. GSK Main Business
Table 84. GSK Latest Developments
Table 85. Sanofi Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 86. Sanofi Childhood Vaccines Product Portfolios and Specifications
Table 87. Sanofi Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 88. Sanofi Main Business
Table 89. Sanofi Latest Developments
Table 90. Merck Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 91. Merck Childhood Vaccines Product Portfolios and Specifications
Table 92. Merck Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 93. Merck Main Business
Table 94. Merck Latest Developments
Table 95. Pfizer Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 96. Pfizer Childhood Vaccines Product Portfolios and Specifications
Table 97. Pfizer Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 98. Pfizer Main Business
Table 99. Pfizer Latest Developments
Table 100. Jintan Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 101. Jintan Childhood Vaccines Product Portfolios and Specifications
Table 102. Jintan Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 103. Jintan Main Business
Table 104. Jintan Latest Developments
Table 105. CSL Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 106. CSL Childhood Vaccines Product Portfolios and Specifications
Table 107. CSL Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 108. CSL Main Business
Table 109. CSL Latest Developments
Table 110. MedImmune LLC Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 111. MedImmune LLC Childhood Vaccines Product Portfolios and Specifications
Table 112. MedImmune LLC Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 113. MedImmune LLC Main Business
Table 114. MedImmune LLC Latest Developments
Table 115. J&J(Crucell) Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 116. J&J(Crucell) Childhood Vaccines Product Portfolios and Specifications
Table 117. J&J(Crucell) Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 118. J&J(Crucell) Main Business
Table 119. J&J(Crucell) Latest Developments
Table 120. China National Biotec Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 121. China National Biotec Childhood Vaccines Product Portfolios and Specifications
Table 122. China National Biotec Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 123. China National Biotec Main Business
Table 124. China National Biotec Latest Developments
Table 125. Tiantan Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 126. Tiantan Childhood Vaccines Product Portfolios and Specifications
Table 127. Tiantan Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 128. Tiantan Main Business
Table 129. Tiantan Latest Developments
Table 130. Hualan Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 131. Hualan Childhood Vaccines Product Portfolios and Specifications
Table 132. Hualan Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 133. Hualan Main Business
Table 134. Hualan Latest Developments
Table 135. Kangtai Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 136. Kangtai Childhood Vaccines Product Portfolios and Specifications
Table 137. Kangtai Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 138. Kangtai Main Business
Table 139. Kangtai Latest Developments
Table 140. Hissen Basic Information, Childhood Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 141. Hissen Childhood Vaccines Product Portfolios and Specifications
Table 142. Hissen Childhood Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2023)
Table 143. Hissen Main Business
Table 144. Hissen Latest Developments
LIST OF FIGURES
Figure 1. Picture of Childhood Vaccines
Figure 2. Childhood Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Childhood Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Childhood Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Childhood Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Childhood Vaccines Sales Market Share by Type in 2022
Figure 14. Global Childhood Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Childhood Vaccines Consumed in Hospital
Figure 16. Global Childhood Vaccines Market: Hospital (2018-2023) & (K Doses)
Figure 17. Childhood Vaccines Consumed in Clinic
Figure 18. Global Childhood Vaccines Market: Clinic (2018-2023) & (K Doses)
Figure 19. Global Childhood Vaccines Sales Market Share by Application (2022)
Figure 20. Global Childhood Vaccines Revenue Market Share by Application in 2022
Figure 21. Childhood Vaccines Sales Market by Company in 2022 (K Doses)
Figure 22. Global Childhood Vaccines Sales Market Share by Company in 2022
Figure 23. Childhood Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Childhood Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Childhood Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Childhood Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 28. Americas Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 30. APAC Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 32. Europe Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Childhood Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Childhood Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Childhood Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Childhood Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Childhood Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Childhood Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Childhood Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Childhood Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Childhood Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Childhood Vaccines
Figure 74. Industry Chain Structure of Childhood Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Childhood Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Childhood Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Childhood Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Childhood Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Childhood Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Childhood Vaccines Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Childhood Vaccines
Figure 2. Childhood Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Childhood Vaccines Sales Growth Rate 2018-2029 (K Doses)
Figure 7. Global Childhood Vaccines Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Childhood Vaccines Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Recombinant Vaccines
Figure 10. Product Picture of Viral Vaccines
Figure 11. Product Picture of Polysaccharide Vaccines
Figure 12. Product Picture of Others
Figure 13. Global Childhood Vaccines Sales Market Share by Type in 2022
Figure 14. Global Childhood Vaccines Revenue Market Share by Type (2018-2023)
Figure 15. Childhood Vaccines Consumed in Hospital
Figure 16. Global Childhood Vaccines Market: Hospital (2018-2023) & (K Doses)
Figure 17. Childhood Vaccines Consumed in Clinic
Figure 18. Global Childhood Vaccines Market: Clinic (2018-2023) & (K Doses)
Figure 19. Global Childhood Vaccines Sales Market Share by Application (2022)
Figure 20. Global Childhood Vaccines Revenue Market Share by Application in 2022
Figure 21. Childhood Vaccines Sales Market by Company in 2022 (K Doses)
Figure 22. Global Childhood Vaccines Sales Market Share by Company in 2022
Figure 23. Childhood Vaccines Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Childhood Vaccines Revenue Market Share by Company in 2022
Figure 25. Global Childhood Vaccines Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Childhood Vaccines Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 28. Americas Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 29. APAC Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 30. APAC Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 31. Europe Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 32. Europe Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Childhood Vaccines Sales 2018-2023 (K Doses)
Figure 34. Middle East & Africa Childhood Vaccines Revenue 2018-2023 ($ Millions)
Figure 35. Americas Childhood Vaccines Sales Market Share by Country in 2022
Figure 36. Americas Childhood Vaccines Revenue Market Share by Country in 2022
Figure 37. Americas Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 38. Americas Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 39. United States Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Childhood Vaccines Sales Market Share by Region in 2022
Figure 44. APAC Childhood Vaccines Revenue Market Share by Regions in 2022
Figure 45. APAC Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 46. APAC Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 47. China Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Childhood Vaccines Sales Market Share by Country in 2022
Figure 55. Europe Childhood Vaccines Revenue Market Share by Country in 2022
Figure 56. Europe Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 57. Europe Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 58. Germany Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Childhood Vaccines Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Childhood Vaccines Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Childhood Vaccines Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Childhood Vaccines Sales Market Share by Application (2018-2023)
Figure 67. Egypt Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Childhood Vaccines Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Childhood Vaccines in 2022
Figure 73. Manufacturing Process Analysis of Childhood Vaccines
Figure 74. Industry Chain Structure of Childhood Vaccines
Figure 75. Channels of Distribution
Figure 76. Global Childhood Vaccines Sales Market Forecast by Region (2024-2029)
Figure 77. Global Childhood Vaccines Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Childhood Vaccines Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Childhood Vaccines Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Childhood Vaccines Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Childhood Vaccines Revenue Market Share Forecast by Application (2024-2029)
